Hideki Garren - Net Worth and Insider Trading
Hideki Garren Net Worth
The estimated net worth of Hideki Garren is at least $13,040 dollars as of 2024-12-01. Hideki Garren is the Director of Coya Therapeutics Inc and owns about 2,000 shares of Coya Therapeutics Inc (COYA) stock worth over $13,040. Hideki Garren is also the Chief Medical Officer of Prothena Corp PLC and owns about 0 shares of Prothena Corp PLC (PRTA) stock worth over $0. Details can be seen in Hideki Garren's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hideki Garren has not made any transactions after 2023-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hideki Garren
Hideki Garren Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hideki Garren owns 2 companies in total, including Prothena Corp PLC (PRTA) , and Coya Therapeutics Inc (COYA) .
Click here to see the complete history of Hideki Garren’s form 4 insider trades.
Insider Ownership Summary of Hideki Garren
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRTA | Prothena Corp PLC | 2023-09-13 | Chief Medical Officer |
| COYA | Coya Therapeutics Inc | 2023-01-03 | director |
Hideki Garren Latest Holdings Summary
Hideki Garren currently owns a total of 2 stocks. Among these stocks, Hideki Garren owns 2,000 shares of Coya Therapeutics Inc (COYA) as of January 3, 2023, with a value of $13,040 and a weighting of 100%. Hideki Garren also owns 0 shares of Prothena Corp PLC (PRTA) as of September 13, 2023, with a value of $0 and a weighting of 0%.
Latest Holdings of Hideki Garren
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COYA | Coya Therapeutics Inc | 2023-01-03 | 2,000 | 6.52 | 13,040 |
| PRTA | Prothena Corp PLC | 2023-09-13 | 0 | 16.21 | 0 |
Holding Weightings of Hideki Garren
Hideki Garren Form 4 Trading Tracker
According to the SEC Form 4 filings, Hideki Garren has made a total of 1 transactions in Coya Therapeutics Inc (COYA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Coya Therapeutics Inc is the acquisition of 2,000 shares on January 3, 2023, which cost Hideki Garren around $9,300.
According to the SEC Form 4 filings, Hideki Garren has made a total of 12 transactions in Prothena Corp PLC (PRTA) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Prothena Corp PLC is the sale of 2,000 shares on September 13, 2023, which brought Hideki Garren around $110,960.
Insider Trading History of Hideki Garren
- 1
Hideki Garren Trading Performance
GuruFocus tracks the stock performance after each of Hideki Garren's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hideki Garren is -12.9%. GuruFocus also compares Hideki Garren's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hideki Garren within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hideki Garren's insider trading performs compared to the benchmark.
Performance of Hideki Garren
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.19 | | | | | |
| Relative Return to S&P 500(%) | -22.36 | | | | | |
Hideki Garren Ownership Network
Hideki Garren Owned Company Details
What does Prothena Corp PLC do?
Who are the key executives at Prothena Corp PLC?
Hideki Garren is the Chief Medical Officer of Prothena Corp PLC. Other key executives at Prothena Corp PLC include See Remarks Karin L Walker , Chief Operating Officer Brandon S. Smith , and Chief Regulatory Officer Carol D. Karp .
Prothena Corp PLC (PRTA) Insider Trades Summary
Over the past 18 months, Hideki Garren made 5 insider transaction in Prothena Corp PLC (PRTA) with a net sale of 18,000. Other recent insider transactions involving Prothena Corp PLC (PRTA) include a net sale of 40,000 shares made by Karin L Walker , a net sale of 40,000 shares made by Carol D. Karp , and a net sale of 21,333 shares made by Brandon S. Smith .
In summary, during the past 3 months, insiders sold 0 shares of Prothena Corp PLC (PRTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 171,333 shares of Prothena Corp PLC (PRTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 171,333 shares.
Prothena Corp PLC (PRTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prothena Corp PLC Insider Transactions
Hideki Garren Mailing Address
Above is the net worth, insider trading, and ownership report for Hideki Garren. You might contact Hideki Garren via mailing address: C/o Prothena Biosciences Inc, 331 Oyster Point Boulevard, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
